C4 Therapeutics, Inc.’s Post

Upcoming FDA/PDUFA Catalysts Calendar for the June 2024 Please stay tuned for the latest biotech catalysts to shape the industry in the coming months. Full free access here: https://lnkd.in/ek7dAfUx Here are some of the key companies with significant upcoming milestones: 💊 $AVTE - Aerovate Therapeutics, Inc. 💊 $IRWD - Ironwood Pharmaceuticals 💊 $PLRX - Pliant Therapeutics 💊 $INSM - Insmed Incorporated 💊 $BMY - Bristol Myers Squibb 💊 $ABEO - Abeona Therapeutics 💊 $BHVN - Biohaven 💊 $MGNX - MacroGenics, Inc. 💊 $SWTX - SpringWorks Therapeutics (also mentioned twice) 💊 $IOVA - Iovance Biotherapeutics, Inc. 💊 $MOR - MorphoSys 💊 $NXTC - NextCure, Inc. 💊 $CYCC - Cyclacel Limited💊 $MURA - Mereo BioPharma 💊 $RCUS - Arcus Biosciences 💊 $BGNE - BeiGene (also mentioned twice) 💊 $KRON - Kronos Bio 💊 $ERAS - Erasca, Inc. 💊 $SNSE - Sensei Biotherapeutics 💊 $CRBP - Corbus Pharmaceuticals...many more Monitor these companies as their innovative treatments progress through critical regulatory reviews. Join the conversation and stay updated on the latest industry developments! #Biotech #Pharma #Investing #FDA #PDUFA #ClinicalTrials #DrugDevelopment #Biopharma

AI is improving speed and reducing costs at every stage of the drug discovery and development process 💊 Rachel Brazil's article for Pharmaceutical Journal Publications explores how AI is accelerating drug discovery, enhancing precision oncology, and cutting costs. From identifying novel targets to streamlining clinical trials, AI is transforming the pharmaceutical industry. Read more about how companies like Recursion, Lantern Pharma Inc. (Nasdaq: LTRN), and BenevolentAI are leading this journey at https://lnkd.in/gBSNG_at #AI #DrugDiscovery #Pharma #Innovation #Pharmaceuticals #AIforDrugDiscovery #AIforHealthcare

🚨 Last Call! Discover Unique Live Cell Insights in Our Exclusive Online Demo Tomorrow! 🚨 🔗 Register Now: https://lnkd.in/dr9C_aNa Attention scientists and researchers in the pharmaceutical drug development industry! Don't miss this unique opportunity to gain live cell insights that are revolutionizing early in vitro and translational research. Our online demo will provide a deep dive into innovative techniques transforming drug discovery and development. Unlock the future of pharmaceutical research with us. See you there! #Pharma #DrugDiscovery #InVitro #TranslationalResearch #LiveCellInsights #Webinar #LastCall

Strategic planning starts in the lead up to launch, right? This is often true, but there are huge advantages to starting early, particularly for novel therapeutics. Download our whitepaper from FirstWord Pharma to explore the benefits and learn what you can do to get ahead: https://loom.ly/grhcxEw #drugdevelopment #strategicplanning #earlystrategy #pharma

It's never to soon to think strategically (but there are lots of reasons that often get in the way). In this article me and my fellow authors explore why early strategic thinking can give you a headstart in the drug development process and help you to avoid some of the potential roadblocks on your journey to patients. We also take a look at why this is even more important in emerging areas like cell and gene therapies where pathways are less established and the landscape is constantly changing

For those involved in strategic planning for novel therapeutics, this excellent whitepaper is worth a read.

Fierce Pharma released their Fierce 15 labeling the top 15 Biotech companies who are leading the way of the future and breaking down barriers. Over the next few weeks i will be posting daily company spotlights deepdiving into the companies on this list telling you all funding activity and the real reasons they are on this list. Companies such as Abdera Therapeutics, Ascidian Therapeutics and BigHat Biosciences plus many more can be seen all on my page. 👀 Keep your eyes peeled... #Companyspotlight #CRO #Contractresearch #ClinicalResearch #Fierce15 #Biotech #Pharmaceuticals

A fantastic article on the importance of early strategic planning for novel therapeutics authored by my wonderful colleagues in Evida and Seques with Manca Povsic from the AMICULUM Access team adding her insights from a market access perspective. Download the white paper to learn more and get in touch with myself or the team if you'd like to discuss your needs in this area. #marketaccess #earlystrategy #pharma #atmp

We had a conversation with Nanda Balasubramanian on the vital role of bioanalysis in propelling pharmaceutical science forward. In this video, Nanda delves into key innovations in bioanalytical techniques aimed at easing the patient burden and enhancing the turnaround times of assays. Bristol Myers Squibb #pharma #bioanalysis #therapeutics